Delivery Order SPE2DB24D2003-SPE2DB25FXMJ5
- Not listed
- The Defense Logistics Agency awarded a $1,154.87 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Sunosi 150 mg tablets (30-count units). This competitive, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by August 13, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $1,420.20 to AmerisourceBergen Drug Corp for the supply of Sunosi 75 mg tablets (30-count units) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed price contract, which is not set-aside, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Sunosi 150 mg tablets (30-count packages) valued at $1,289.19. This firm fixed-price delivery order will be completed by August 19, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The award was not set aside for...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $2,404.99 for 30 tablets of Sunosi 75 mg on August 1, 2025, with an ultimate completion date of August 4, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed price terms and represents a child award under AmerisourceBergen's larger federal contract vehicle. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Sunosi 150 mg tablets (30-count units) with a contract value of $2,570.36 and a firm fixed price structure. This delivery order, valued at the ceiling amount specified, represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The work is to be performed at the company's corporate office in Conshohocken, Pennsylvania, and the...
- AmerisourceBergen Drug Corp received a delivery order valued at $4,627.82 from the Defense Logistics Agency (DLA) on July 22, 2025, for the supply of Sunosi 75 mg tablets (30-count units). This firm fixed-price contract, which is non-set-aside and competitively awarded, is scheduled for completion by July 23, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $2,445.76 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Sunosi 150 mg tablets (30-count). This firm fixed-price contract represents a non-set-aside competitive award and is scheduled for completion by September 5, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $1,089.60 to AmerisourceBergen Drug Corp for the supply of Sunosi 150 mg tablets (30-count units). This competitively awarded, firm fixed-price delivery order was issued on July 23, 2025, with an ultimate completion date of July 24, 2025. The contract represents a direct procurement action under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Sunosi 150 mg tablets (30-count units) with a contract ceiling value of $2,746.87. This is a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through competitive procurement. The contract is classified as a child award, meaning it derives from a larger indefinite delivery contract vehicle. Performance will be executed from the vendor's...
- The Defense Logistics Agency awarded a $1,817.13 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 tablets of Sunosi 150 mg, with an ultimate completion date of August 13, 2025. This non-set-aside contract was competitively awarded and represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken,...
- SPE2DB24D2003Indefinite Delivery Contract
- SPE2DB24D2003-SPE2DB25FXMJ5Delivery Order
The Defense Logistics Agency awarded a $4,025.37 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Sunosi 150 mg tablets (30-count package). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 5, 2025, and performance executed from the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as the primary vehicle for comprehensive pharmaceutical and medical supply support to military healthcare systems worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider serving as a critical federal vendor for military and veteran medical procurement. The company was competitively awarded this delivery order based on its established capability to meet federal pharmaceutical supply requirements. The underlying indefinite delivery contract encompasses a broad range of pharmaceutical products, generic and brand-name medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 9/4/25 |